Annual CAPEX
$54.59 M
+$9.65 M+21.48%
31 December 2023
Summary:
Genmab A/S annual capital expenditures is currently $54.59 million, with the most recent change of +$9.65 million (+21.48%) on 31 December 2023. During the last 3 years, it has risen by +$7.55 million (+16.05%). GMAB annual CAPEX is now -77.05% below its all-time high of $237.85 million, reached on 31 December 2008.GMAB CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$7.24 M
+$3.38 M+87.55%
01 September 2024
Summary:
Genmab A/S quarterly capital expenditures is currently $7.24 million, with the most recent change of +$3.38 million (+87.55%) on 01 September 2024. Over the past year, it has dropped by -$7.05 million (-49.32%). GMAB quarterly CAPEX is now -88.60% below its all-time high of $63.54 million, reached on 30 September 2018.GMAB Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$24.64 M
-$7.05 M-22.23%
01 September 2024
Summary:
Genmab A/S TTM capital expenditures is currently $24.64 million, with the most recent change of -$7.05 million (-22.23%) on 01 September 2024. Over the past year, it has dropped by -$37.39 million (-60.27%). GMAB TTM CAPEX is now -67.45% below its all-time high of $75.72 million, reached on 31 December 2018.GMAB TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GMAB CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +21.5% | -49.3% | -60.3% |
| 3 y3 years | +16.1% | -38.8% | -33.6% |
| 5 y5 years | -27.9% | +6.5% | +47.2% |
GMAB CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +36.1% | -57.2% | +87.5% | -60.3% | at low |
| 5 y | 5 years | -27.9% | +228.0% | -66.2% | +87.5% | -60.3% | +48.1% |
| alltime | all time | -77.0% | >+9999.0% | -88.6% | >+9999.0% | -67.5% | +4159.4% |
Genmab A/S CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $7.24 M(+87.5%) | $24.64 M(-22.2%) |
| June 2024 | - | $3.86 M(-5.3%) | $31.69 M(-27.4%) |
| Mar 2024 | - | $4.08 M(-56.9%) | $43.67 M(-20.0%) |
| Dec 2023 | $54.59 M(+21.5%) | $9.47 M(-33.7%) | $54.59 M(-12.0%) |
| Sept 2023 | - | $14.29 M(-9.8%) | $62.04 M(+7.2%) |
| June 2023 | - | $15.84 M(+5.6%) | $57.88 M(+12.7%) |
| Mar 2023 | - | $15.00 M(-11.3%) | $51.34 M(+14.2%) |
| Dec 2022 | $44.94 M(+12.1%) | $16.91 M(+67.0%) | $44.94 M(+15.4%) |
| Sept 2022 | - | $10.13 M(+9.0%) | $38.95 M(-4.2%) |
| June 2022 | - | $9.30 M(+8.1%) | $40.65 M(-7.9%) |
| Mar 2022 | - | $8.60 M(-21.3%) | $44.16 M(+10.1%) |
| Dec 2021 | $40.10 M(-14.8%) | $10.93 M(-7.6%) | $40.10 M(+8.1%) |
| Sept 2021 | - | $11.83 M(-7.6%) | $37.09 M(+7.8%) |
| June 2021 | - | $12.80 M(+182.0%) | $34.40 M(-20.0%) |
| Mar 2021 | - | $4.54 M(-42.7%) | $43.02 M(-8.6%) |
| Dec 2020 | $47.04 M(+182.6%) | $7.92 M(-13.3%) | $47.04 M(+8.0%) |
| Sept 2020 | - | $9.14 M(-57.3%) | $43.54 M(+5.7%) |
| June 2020 | - | $21.42 M(+150.1%) | $41.21 M(+87.2%) |
| Mar 2020 | - | $8.56 M(+93.4%) | $22.01 M(+32.2%) |
| Dec 2019 | $16.64 M(-78.0%) | $4.43 M(-34.9%) | $16.64 M(-0.6%) |
| Sept 2019 | - | $6.80 M(+206.3%) | $16.74 M(-77.2%) |
| June 2019 | - | $2.22 M(-30.5%) | $73.48 M(-0.9%) |
| Mar 2019 | - | $3.20 M(-29.4%) | $74.17 M(-2.0%) |
| Dec 2018 | $75.72 M(+458.9%) | $4.52 M(-92.9%) | $75.72 M(+2.1%) |
| Sept 2018 | - | $63.54 M(+2082.6%) | $74.19 M(+384.5%) |
| June 2018 | - | $2.91 M(-38.7%) | $15.31 M(-13.7%) |
| Mar 2018 | - | $4.75 M(+58.4%) | $17.74 M(+31.0%) |
| Dec 2017 | $13.55 M(+175.3%) | $3.00 M(-35.7%) | $13.55 M(-4.5%) |
| Sept 2017 | - | $4.66 M(-12.7%) | $14.19 M(+45.6%) |
| June 2017 | - | $5.34 M(+866.5%) | $9.74 M(+100.2%) |
| Mar 2017 | - | $552.40 K(-84.8%) | $4.87 M(-1.1%) |
| Dec 2016 | $4.92 M | $3.64 M(+1583.8%) | $4.92 M(+37.8%) |
| Sept 2016 | - | $216.00 K(-53.2%) | $3.57 M(-6.7%) |
| June 2016 | - | $461.50 K(-23.9%) | $3.83 M(-78.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | $606.80 K(-73.5%) | $17.76 M(-11.8%) |
| Dec 2015 | $20.14 M(+49.7%) | $2.29 M(+385.2%) | $20.14 M(+8.7%) |
| Sept 2015 | - | $471.40 K(-96.7%) | $18.53 M(-37.8%) |
| June 2015 | - | $14.39 M(+381.4%) | $29.78 M(+84.9%) |
| Mar 2015 | - | $2.99 M(+341.6%) | $16.11 M(+19.7%) |
| Dec 2014 | $13.46 M(+629.1%) | $677.10 K(-94.2%) | $13.46 M(-1.9%) |
| Sept 2014 | - | $11.72 M(+1520.4%) | $13.72 M(+434.9%) |
| June 2014 | - | $723.10 K(+113.4%) | $2.57 M(+22.8%) |
| Mar 2014 | - | $338.90 K(-64.1%) | $2.09 M(+13.2%) |
| Dec 2013 | $1.85 M(+18.8%) | $943.00 K(+68.4%) | $1.85 M(+8.9%) |
| Sept 2013 | - | $560.10 K(+126.2%) | $1.69 M(+16.1%) |
| June 2013 | - | $247.60 K(+160.9%) | $1.46 M(-1.9%) |
| Mar 2013 | - | $94.90 K(-88.0%) | $1.49 M(-4.3%) |
| Dec 2012 | $1.55 M(+15.5%) | $791.40 K(+143.5%) | $1.55 M(+34.9%) |
| Sept 2012 | - | $325.00 K(+17.5%) | $1.15 M(+9.3%) |
| June 2012 | - | $276.60 K(+71.8%) | $1.05 M(-12.2%) |
| Mar 2012 | - | $161.00 K(-58.6%) | $1.20 M(-10.9%) |
| Dec 2011 | $1.35 M(-25.2%) | $389.20 K(+71.6%) | $1.35 M(-20.7%) |
| Sept 2011 | - | $226.80 K(-46.3%) | $1.70 M(-15.1%) |
| June 2011 | - | $422.70 K(+37.6%) | $2.00 M(-2.1%) |
| Mar 2011 | - | $307.10 K(-58.5%) | $2.04 M(+13.3%) |
| Dec 2010 | $1.80 M(-42.7%) | $739.50 K(+40.2%) | $1.80 M(+15.1%) |
| Sept 2010 | - | $527.40 K(+13.2%) | $1.56 M(-18.2%) |
| June 2010 | - | $465.90 K(+594.3%) | $1.91 M(-27.3%) |
| Mar 2010 | - | $67.10 K(-86.7%) | $2.63 M(-16.3%) |
| Dec 2009 | $3.14 M(-98.7%) | $503.00 K(-42.5%) | $3.14 M(+19.1%) |
| Sept 2009 | - | $874.80 K(-26.1%) | $2.64 M(+49.6%) |
| June 2009 | - | $1.18 M(+104.5%) | $1.76 M(+204.5%) |
| Mar 2009 | - | $578.60 K | $578.60 K |
| Dec 2008 | $237.85 M(+9640.6%) | - | - |
| Dec 2007 | $2.44 M(+647.6%) | - | - |
| Dec 2006 | $326.60 K(-19.7%) | - | - |
| Dec 2005 | $406.50 K(-70.6%) | - | - |
| Dec 2004 | $1.38 M(-38.2%) | - | - |
| Dec 2003 | $2.24 M | - | - |
FAQ
- What is Genmab A/S annual capital expenditures?
- What is the all time high annual CAPEX for Genmab A/S?
- What is Genmab A/S annual CAPEX year-on-year change?
- What is Genmab A/S quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Genmab A/S?
- What is Genmab A/S quarterly CAPEX year-on-year change?
- What is Genmab A/S TTM capital expenditures?
- What is the all time high TTM CAPEX for Genmab A/S?
- What is Genmab A/S TTM CAPEX year-on-year change?
What is Genmab A/S annual capital expenditures?
The current annual CAPEX of GMAB is $54.59 M
What is the all time high annual CAPEX for Genmab A/S?
Genmab A/S all-time high annual capital expenditures is $237.85 M
What is Genmab A/S annual CAPEX year-on-year change?
Over the past year, GMAB annual capital expenditures has changed by +$9.65 M (+21.48%)
What is Genmab A/S quarterly capital expenditures?
The current quarterly CAPEX of GMAB is $7.24 M
What is the all time high quarterly CAPEX for Genmab A/S?
Genmab A/S all-time high quarterly capital expenditures is $63.54 M
What is Genmab A/S quarterly CAPEX year-on-year change?
Over the past year, GMAB quarterly capital expenditures has changed by -$7.05 M (-49.32%)
What is Genmab A/S TTM capital expenditures?
The current TTM CAPEX of GMAB is $24.64 M
What is the all time high TTM CAPEX for Genmab A/S?
Genmab A/S all-time high TTM capital expenditures is $75.72 M
What is Genmab A/S TTM CAPEX year-on-year change?
Over the past year, GMAB TTM capital expenditures has changed by -$37.39 M (-60.27%)